Retatrutide

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP and glucagon receptors, supplied by MyPeptides for laboratory research use only.

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP and glucagon receptors. MyPeptides supplies it as a lyophilised 5 mg vial for in vitro laboratory research, HPLC assayed at ≥99% purity with a signed certificate of analysis on every batch.

Researchers reach for Retatrutide in metabolic, body-composition and incretin-signalling research. It is offered strictly for laboratory investigation — no personal-use claims, no dosing guidance, and no framing as a medicine.

The point of buying research grade rather than generic material is documentation. Every Retatrutide order carries lot-specific HPLC and mass-spec data, so the compound in your protocol matches the compound named on the paperwork. One of the few triple agonists available at research grade — HPLC assayed with a signed CoA per batch.